AI assistant
Sending…
GENTEX CORP — Director's Dealing 2013
May 28, 2013
30893_dirs_2013-05-28_52e33bc0-c8b7-4ea8-99a7-d60c350db029.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2013-05-21
Reporting Person: Downing Steven R (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6475 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $14.30 | 2013-09-30 | Common Stock (648) | Direct | |
| Employee Stock Option (Right to Buy) | $14.25 | 2014-09-28 | Common Stock (1750) | Direct | |
| Employee Stock Option (Right to Buy) | $19.525 | 2015-09-30 | Common Stock (3150) | Direct | |
| Employee Stock Option (Right to Buy) | $24.96 | 2016-09-29 | Common Stock (4410) | Direct | |
| Employee Stock Option (Right to Buy) | $17.27 | 2019-09-27 | Common Stock (5000) | Direct |
Footnotes
F1: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date.
F2: Options granted under the Gentex Corporation Employee Stock Option Plan which is a Rule 16B plan.
F3: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19